SOLICITATION NOTICE
66 -- G-Rex100 Gas Permeable Cell Culture Devices
- Notice Date
- 6/15/2012
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd., EPS Suite 600, Rockville, Maryland, 20852
- ZIP Code
- 20852
- Solicitation Number
- N02CO26003-28
- Archive Date
- 7/17/2012
- Point of Contact
- Laura Glockner, Phone: 3014968607
- E-Mail Address
-
laura.glockner@nih.gov
(laura.glockner@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Boulevard, EPS Suite 600, Room 6068, Rockville, MD 20852, UNITED STATES. Description The National Cancer Institute (NCI), Surgery Branch, Cell Production Facility plans to procure on a sole source basis from Wilson Wolf Manufacturing Corporation, 33-5th Avenue NW, New Brighton, MN 55112 for G-Rex100 Gas Permeable Cell Culture Devices to support its clinical protocols. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 15, Contracting by Negotiation. The North American Industry Classification System Code is 334516 and the business size standard is 500 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price, indefinite delivery indefinite quantity (IDIQ) type contract. The Period of Performance shall be for twelve (12) months with four (4) option periods of twelve (12) months. During the base period, the contractor shall deliver a minimum of 1800 and a maximum of 3600 G-Rex100 Gas Permeable Cell Culture Devices. During option period 1, the contractor shall deliver a minimum of 1000 and a maximum of 3600 G-Rex100 Gas Permeable Cell Culture Devices. During option period 2, the contractor shall deliver a minimum of 1000 and a maximum of 3600 G-Rex100 Gas Permeable Cell Culture Devices. During option period 3, the contractor shall deliver a minimum of 1000 and a maximum of 3600 G-Rex100 Gas Permeable Cell Culture Devices. During option period 4, the contractor shall deliver a minimum of 1000 and a maximum of 3600 G-Rex100 Gas Permeable Cell Culture Devices. It has been determined that there is no opportunity to acquire green products or services under this procurement. The Surgery Branch, National Cancer Institute (SB/NCI) has an ongoing clinical program using adoptive cell transfer therapy for the treatment of patients with metastatic cancer. The cell production laboratory of the SB/NCI uses a number of techniques to identify, purify and expand tumor reactive T lymphocytes from patients with advanced cancer. For adoptive transfer protocols only equipment and reagents that are produced in accordance with good manufacturing practices (GMP) can be utilized to expand patient cells, as mandated by the FDA. The Surgery Branch, National Cancer Institute (SB/NCI) requires a series of gas permeable flasks to successfully expand patient cells for adoptive cell therapy. These flasks are critical for the successful expansion of patient cells, to high densities, under static conditions, while providing enhanced aeration. Static culture conditions are essential for the early stages of lymphocyte expansions, where uninterrupted contact with feeder cells is necessary to provide the essential co-stimulatory signals to initiate a successful patient treatment. The NCI plans to use these gas permeable flasks to expand patient cells for the following clinical protocols and all subsequent protocols (08-C-0181; 10-C-0166; 11-C-0123; 11-C-0163; 11-C-0170; 11-C-0260; 12-C-0045; 12-C-0114; and 12-C-0116). These protocols require the rapid expansion of patients' cells in as small a volume of media as possible in order to facilitate harvesting and washing of the cell product. The required flasks shall be gamma irradiated, single unit gas-culture-permeable devices with a 100 cm2 culture area, a 500 ml medium capacity, and capable of holding 1 billion cells. The required flask size is 4.5" diameter by 4" high as required by the SB/NCI incubator. Wilson Wolf Manufacturing is the sole known supplier of G-Rex100 Gas Permeable Cell Culture Devices. No other known product is available that is able to support T lymphocyte rapid expansions from initiation to conclusion in dense static culture conditions. As the product is proprietary, Wilson Wolf Manufacturing is the only known source. This is not a solicitation for competitive proposals. However, if any interested party believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisitions on or before 11:00 AM EST on July 2, 2012. No electronic capability statements will be accepted (i.e. email or fax). An original and one copy must be sent to the NCI Office of Acquisitions at the address stated above. All questions must be in writing and can be faxed (301) 402-4513 or emailed to Laura Glockner, Contract Specialist, at laura.glockner@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) www.ccr.gov and the Online Representations and Certifications Applications (ORCA), http://orca.bpn.gov. No collect calls will be accepted. Please reference solicitation number N02CO26003-28 on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N02CO26003-28/listing.html)
- Record
- SN02777366-W 20120617/120615235041-38e7e0dbd86b0dea1c4a8ffdf9a788fa (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |